Honorable Jack Quinn
Remarks
Oversight Hearing on Persian Gulf Claims
Processing,
Hepatitis C and Cerebral Malaria
July 16, 1998
Good Morning. The Subcommittee will come to order.
We are here today to discuss several issues confronting the Department of Veterans
Affairs. First, what progress has the Department made in ensuring consistent and fair
processing of Persian Gulf War veterans compensation claims. We have seen the
Department go from processing claims at the Regional Offices to centralizing processing at
four regional centers and now back to the ROs. Throughout each of those moves, we
have been told that the latest decision would clean up the processing problem.
Unfortunately, I am not convinced. In the past few months, the Department finally admitted
that its data collection scheme was faulty and began an effort to improve its data.
However, after considerable efforts to systematize data collection, the staff member
responsible has now been assigned temporary duties away from the Department. I am very
disappointed to see that and I hope the Department will inform the Subcommittee how it
will continue to improve its data on Persian Gulf claims.
The issue of exposure to depleted uranium, which was widely used in various munitions
during the Gulf War, has made the press recently. My understanding is that depleted
uranium is a toxic heavy metal and potentially dangerous. I would note this problem is not
limited to those who fought in the Gulf War because DU is still being used on firing
ranges by all the services, so our people are still being exposed to DU. For example,
somebody has to clean the weapons after they have been fired. Therefore, I am asking the
Department to coordinate a VA-DoD briefing on the issues surrounding the exposure to
depleted uranium within the next 30 days .
Second, we have asked the Department to discuss how it is handling claims involving
Hepatitis C. This is a deadly disease that has been making the front pages of news
magazines and some scientists are saying a bigger threat to the national health than AIDS.
I want to be sure that if a vet shows up at the VA with Hep C and evidence of a possible
infection opportunity while in the service, the vet will be taken care of. Initial VA data
does not show that necessarily to be the case. So, my question to the Department right up
front is do current laws and regulations inhibit a veterans ability to be
service-connected for Hepatitis C if he or she received a blood transfusion prior to the
early 1990s or worked in the medical field?
Our final topic concerns the possibility that veterans who are judged to be suffering
from PTSD may actually be exhibiting the effects of cerebral malaria. I am looking forward
to hearing the Departments views on the study done by Dr. Varny and others.
Finally, I want to spend just a moment on what I see as the value and obligation of the
VA research program. Todays hearing revolves around three examples of how VA
research can contribute to a veterans ability to be compensated for disabilities incurred
in service. While this subcommittee does not have jurisdiction over VAs research
program, I want to make a point about how VA chooses research topics. I am concerned that
VA research has lost its focus on problems, that while not necessarily unique to veterans,
occur with greater frequency than in the non-veteran population, and we will hear
testimony today reflecting my concern. To put it in perspective, an R&D program
focused on the relevant issues affecting large numbers of veterans is vital to a fair
compensation program. Typically, these are problems that our troops encountered in the
field or the workplace throughout this century - things like tropical diseases, cold
weather injuries, combat-related stress, exposure to radiation or hazardous materials. My
question is, what portion of the VAs $300 million R&D appropriation is going to
directly address these types of problems? I would appreciate an answer from the Department
by next Wednesday.
Before we begin, without objection, I would like to enter a letter from Chairman Stump
to Secretary West into the record. Copies are available on the table. In his letter,
Chairman Stump has asked the Secretary to review implementation of compensation laws on
undiagnosed illnesses to determine whether chronic fatigue syndrome and fibro myalgia
should be considered equivalent to undiagnosed illness for compensation purposes. The
Chairman makes the point that two veterans with exactly the same symptoms could be
diagnosed completely differently by VA physicians, with one receiving a diagnosis of CFS
or fibro myalgia and the other suffering from undiagnosed illness. I believe the
Legions prepared statement does a very good job of making the case in support of the
Chairmans position. I look forward to hearing the Departments views on the
Chairman Stumps letter.
I now yield to the Ranking Member of the Subcommittee, Bob Filner for any opening
remarks he may have.
Do any other members have opening remarks?
Could we have the first panel, please. Today, we have with us Mr. Bob Epply, Director
of the Compensation and Pension Service and Dr. Teresa Wright, Dr. Nils Varny, and Dr.
John Booss (BOOZE). Before you start, I would like to request an explanation of each of
the 29 Hepatitis claims denied by the Board on the grounds of being not well grounded by
the end of next week. Please proceed.
Thank you. I have a couple questions for this panel.
I now yield to the Ranking Member for any questions he may have.
Do any of the other Members have questions for this panel?
Could we have our second panel, please. We are delighted to have Paul Sullivan from The
National Gulf War Resource Center. Paul, I am impressed with the quality of your written
testimony and I look forward to a long and positive working relationship with the Resource
Center. Your full testimony will be entered into the record, so if you would, please begin
with your summary.
Thank you Paul.
Bob do you have anything for Mr. Sullivan?
Do any of the other Members have questions for Mr. Sullivan?
Thank you, Paul. Could we have the next panel, please.
Chairman Bill Redmond
(assuming Chair for Chairman Quinn)
July 16, 1998
Our final panel is composed of representatives from the Veterans Service Organizations.
Bill Russo, Matt Puglisi, Bill Frasure, and Phil Ridley will represent the VVA, the
Legion, the VFW, and the DAV respectively. Gentlemen, please begin.
Thank you. Let me start the questioning.
I want to thank all of todays witnesses. But more importantly, I would like the
Department to understand that they are still deficient in their data collection and I
believe they need to do whatever it takes to get the data question straightened out.
The hearing stands adjourned. |